UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Kosmos Energy
KOS
$1.7B
| $4.81M | ﹤0.01% |
2,281,727
-1,871,951
| -45% | -$5.21M |
|
1602
Edgewise Therapeutics
EWTX
$4.76B
| $4.8M | ﹤0.01% |
118,209
+3,489
| +3% | +$120K |
|
1603
Dentsply Sirona
XRAY
$2.19B
| $4.8M | ﹤0.01% |
452,599
-182,661
| -29% | -$1.99M |
|
1604
HSBC
HSBC
$364B
| $4.8M | ﹤0.01% |
50,430
| – | – |
|
1605
Adaptive Biotechnologies
ADPT
$3.88B
| $4.77M | ﹤0.01% |
222,280
-244
| -0.1% | -$3.74K |
|
1606
Archer Aviation
ACHR
$4.49B
| $4.77M | ﹤0.01% |
1,007,491
-113,857
| -10% | -$662K |
|
1607
Enerpac Tool Group
EPAC
$1.89B
| $4.76M | ﹤0.01% |
132,867
-21,221
| -14% | -$744K |
|
1608
Arcus Biosciences
RCUS
$3.7B
| $4.76M | ﹤0.01% |
154,398
-3,894
| -2% | -$96.2K |
|
1609
DNOW Inc
DNOW
$2.92B
| $4.76M | ﹤0.01% |
366,962
-2,572
| -0.7% | -$33.4K |
|
1610
BigBear.ai
BBAI
$1.4B
| $4.75M | ﹤0.01% |
1,295,272
+76,451
| +6% | +$306K |
|
1611
Madison Square Garden
MSGE
$3.63B
| $4.7M | ﹤0.01% |
58,150
+6,474
| +13% | +$442K |
|
1612
Helios Technologies
HLIO
$2.35B
| $4.7M | ﹤0.01% |
52,643
-1,766
| -3% | -$136K |
|
1613
Nelnet
NNI
$4.48B
| $4.69M | ﹤0.01% |
35,200
+7,966
| +29% | +$1.06M |
|
1614
JPMorgan Income ETF
JPIE
$10.7B
| $4.69M | ﹤0.01% |
101,877
| – | – |
|
1615
Towne Bank
TOWN
$3.43B
| $4.69M | ﹤0.01% |
129,453
-8,108
| -6% | -$283K |
|
1616
Centuri Holdings
CTRI
$2.09B
| $4.68M | ﹤0.01% |
154,614
+6,216
| +4% | +$201K |
|
|
HAPN
1617
Happen Inc
HAPN
$2.02B
| $4.67M | ﹤0.01% |
225,020
-109,620
| -33% | -$1.87M |
|
1618
Huntsman Corp
HUN
$1.72B
| $4.67M | ﹤0.01% |
439,420
-40,199
| -8% | -$554K |
|
1619
ImmunityBio
IBRX
$8.79B
| $4.66M | ﹤0.01% |
531,957
-718
| -0.1% | -$5.43K |
|
1620
Green Brick Partners
GRBK
$3.02B
| $4.66M | ﹤0.01% |
58,162
-6,499
| -10% | -$449K |
|
|
UNIT
1621
Uniti Group
UNIT
$2.49B
| $4.65M | ﹤0.01% |
405,609
+7,558
| +2% | +$85.7K |
|
1622
Vanguard FTSE Europe ETF
VGK
$30.9B
| $4.64M | ﹤0.01% |
52,415
-138,629
| -73% | -$12.1M |
|
|
HNGE
1623
Hinge Health
HNGE
$7.48B
| $4.64M | ﹤0.01% |
55,913
+31,550
| +129% | +$1.71M |
|
1624
StepStone Group
STEP
$4.18B
| $4.63M | ﹤0.01% |
111,890
-600
| -0.5% | -$29.7K |
|
1625
Gorman-Rupp
GRC
$1.99B
| $4.62M | ﹤0.01% |
50,332
-326
| -0.6% | -$24.8K |
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.